Skip to main content
Daito Pharmaceutical Co., Ltd. logo

Daito Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 4577 ISIN · JP3486150000 T Manufacturing
Filings indexed 76 across all filing types
Latest filing 2015-10-09 Interim / Quarterly Rep…
Country JP Japan
Listing T 4577

About Daito Pharmaceutical Co., Ltd.

https://www.eng.daitonet.co.jp/

Daito Pharmaceutical Co., Ltd. is a manufacturer specializing in the integrated production of pharmaceuticals, from active pharmaceutical ingredients (APIs) to finished formulation products. The company's core activities include the development and supply of APIs, primarily for generic drugs, and the manufacturing of generic and over-the-counter (OTC) medications. Additionally, Daito provides contract manufacturing services for various pharmaceutical products. The company emphasizes a comprehensive quality assurance system to ensure the stable supply of high-quality products to its clients.

Recent filings

Filing Released Lang Actions
四半期報告書-第74期第1四半期(2015/06/01-2015/08/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '第1四半期報告書' (Quarterly Report) for Daito Pharmaceutical Co., Ltd., covering the period from June 1, 2015, to August 31, 2015. It contains detailed financial statements, including the balance sheet, income statement, and notes to the financial statements, as required by the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2016
2015-10-09 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.